A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan

NCT04070313 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
36
Enrollment
INDUSTRY
Sponsor class

Stopped Study treatment is to use TS-1 (mono-chemotherapy agent) in adjuvant setting for pancreatic cancer, which may be less clinical benefit compared to combination therapy according to current trend at investigators' discretion.

Conditions

Interventions

Sponsor

TTY Biopharm

Collaborators